EMA Withdrawn: Clopidogrel Teva Pharma (previously Clopidogrel HCS) (clopidogrel (as hydrochloride)) — Teva B.V.

View source ↗

Summary

EMA withdrew Clopidogrel Teva Pharma (clopidogrel hydrochloride) from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Peripheral Vascular Diseases
• Stroke

Drugs mentioned

• Clopidogrel Teva Pharma (clopidogrel (as hydrochloride))

Snippet

Status: Withdrawn. Therapeutic area: Myocardial Infarction;Peripheral Vascular Diseases;Stroke. MAH: Teva B.V.. Decision date: 22/01/2016